Sialic acid concentration in different stages of malignant lymphoma and leukemia in children

Pediatrics International

Volumn 39, Issue 4, 1997, Pages 448-450

  Tomaszewska, Renata ^a   Sonta Jakimczyk, Danuta ^a   Dyduch, Antoni ^a   Olejnik, Igor ^a   Mazur, Bogdan ^a  

^a Silesian Center of Cardiology   (Poland)

Author keywords

Leukemia; Lymphoma; Monitoring; Sialic acid

Indexed keywords

SIALIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD LEVEL; CANCER STAGING; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; INFANT; LEUKEMIA REMISSION; LYMPHOMA; MAJOR CLINICAL STUDY; NEWBORN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LEUKEMIA; LYMPHOMA; N-ACETYLNEURAMINIC ACID; NEOPLASM STAGING;

EID: 0030764938     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03615.x     Document Type: Article

References (15)

1. Bosmann H., Hall T. Enzyme activity in invasive tumors of human breast and colon. Proc. Natl Acad. Sci. USA 1974; 71: 1833–7.
2. Shamberger RJ. Serum sialic acid in normals and in cancer patients. J. Clin. Biochem. 1984; 22: 647–51.
3. Hulbert, Silver KB, Karim AK, Archibald LE, Salinas AF. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Cancer Res. 1979; 39: 503–642.
4. Dnistrian AM, Schwartz MK, Katopodis N., Fracchia AA, Stock CC. Serum lipid-bound sialic acid as a marker in breast cancer. Cancer 1982; 50: 1815–19.
5. Dwivedi C., Dixit M., Kumar SS, Reddy H., Semenya KA, Hardy RE. Plasma sialic acid alterations in neoplastic diseases. J. Med. 1987; 18: 323–32.
6. Schulze G. Sialinsaure im Serum: ein Indikator fur malignes Wachstum? Arch. Geschwulstforsch. 1990; 60: 19 (in German).
7. Dnistrian AM, Schwartz MK. Lipid-bound sialic acid as a tumor marker. Ann. Clin. Lab. Sci. 1983; 13: 137–42.
8. Patel PS, Adhvaryu SG, Baxi BR. Tumor markers in leukemia: evaluation of serum levels of different forms of sialic acid, Regan isoenzyme and lactate dehydrogenase. Int. J. Biol. Markers 1991; 6: 177–82.
9. Patel PS, Baxi BR, Balar DB. Significance of serum sialoglycoproteins in patients with lung cancer. Neoplasma 1989; 36: 53–9.
10. Petru E., Sevin BU, Averette HE, Koechli OR, Perras JP, Hilsenbeck S. Comparison of three tumor markers—CA-125, lipid-associated sialic acid (LSA), and NB/70K—in monitoring ovarian cancer. Gynecol. Oncol. 1990; 38: 181–6.
11. Adamo V., Altavilla G., Caristi N. et al. Comportamento del livello sierico dell' acido sialico in momenti diversi della malattia neoplastica. Minerva Med. 1985; 76: 2067 (in Ital. with Eng. abstr.).
12. Simm Sz, Markowska J., Tomaszkiewicz T., Herwichowska K. Wstȩpna ocena przydatności oznaczania poziomu fukozy i kwasu sjalowego u kobiet chorych na nowotwory narza̧dów plciowych. Gin. Pol. 1979; 50: 957 (in Polish).
13. Potter MN. The detection of minimal residual disease in acute lymphoblastic leukaemia. Blood Rev. 1992; 6: 68–82.
14. Seider A., Graf N., Sitzmann FC. Wertigkeit der Sialins-aurebestimmung im Serum bei Kindern. Päd. und Pädol. 1992; 27: 43 (in German).
15. O'Kennedy R., Berns G., Moran E. et al. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett. 1991; 58: 91.